MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
AMRN Amarin
- 0.460
- -0.006-1.18%
Close Dec 20 16:00 ET
- 0.490
- +0.030+6.50%
Post 20:01 ET
189.22MMarket Cap-4.60P/E (TTM)
0.493High0.460Low2.52MVolume0.470Open0.466Pre Close1.22MTurnover0.66%Turnover RatioLossP/E (Static)411.34MShares1.37052wk High0.36P/B176.50MFloat Cap0.43052wk Low--Dividend TTM383.70MShs Float675.000Historical High--Div YieldTTM7.13%Amplitude0.430Historical Low0.483Avg Price1Lot Size
About Amarin Company
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Company Profile
SymbolAMRN
Company NameAmarin
Listing DateApr 1, 1993
Issue Price6.00
Founded1989
CEOMr. Aaron D. Berg
MarketNASDAQ
Employees275
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressIconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-6699-020
Websitehttp://www.amarincorp.com
Company Executives
- Name
- Position
- Salary
- Aaron D. Berg
- Director, President and Chief Executive Officer
- 2.45M
- Peter Fishman
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Steven B. Ketchum, PhD
- Executive Vice President, President, Research and Development and Chief Scientific Officer
- 2.35M
- Jonathan N. Provoost
- Executive Vice President, Chief Legal and Compliance Officer and Secretary
- 659.26K
- Dr. Odysseas D. Kostas, M.D.
- Chairman of the Board
- 650.41K
- Oliver O'Connor
- Independent Director
- 611.85K
- Keith L. Horn
- Independent Director
- 632.09K
- Mark DiPaolo, Esq.
- Independent Director
- 621.00K
- Dr. Paul Cohen, M.D.
- Independent Director
- 622.06K
- Patrice Bonfiglio
- Independent Director
- 626.87K
- Diane E. Sullivan
- Independent Director
- 630.83K
- Louis Sterling, III
- Independent Director
- 629.35K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.